The authors discuss why defining adaptive immune resistance mechanisms at the tumour site should be a key focus to direct future drug development as well as practical approaches to improve current cancer therapy.
[Nature Reviews Drug Discovery]
Home Newsletters Human Immunology News Adaptive Immune Resistance at the Tumour Site: Mechanisms and Therapeutic Opportunities
